Pierre Gravier
CHIEF FINANCIAL OFFICER · PTC THERAPEUTICS, INC.
- 2025
- Jul 16, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pierre Gravier files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil Gregory Almstead - $16.35M in PTCT purchases and sales in the last 12 months
- Michael Schmertzler - $6.47M in PTCT purchases and sales in the last 12 months
- Mark Elliott Boulding - $4.08M in PTCT purchases and sales in the last 12 months
- Matthew B. Klein - $3.60M in PTCT purchases and sales in the last 12 months
- Eric Pauwels - $2.61M in PTCT purchases and sales in the last 12 months
- Emma Reeve - $2.49M in PTCT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pierre Gravier?
Pierre Gravier is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of PTC THERAPEUTICS, INC. (PTCT). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Pierre Gravier last file a Form 4?
The most recent primary Form 4 on record is dated 16 July 2026, one of 5 filings going back to 2025.
Has Pierre Gravier been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($777K) across all tracked filings.
